Reinhard Klingel from Apherese ForschungsInstitut - AFI | Apheresis Research Institute reporting long term follow up of #lipoprotein #apheresis at the 23rd #apheresis therapy seminar. For more details read the accompanying paper link.springer.com/article/10.1...

Vega Goedecke from #Medical School Hannover presenting the baseline data from #EXTINCT #postcovid study to treat #MECSF / #Longcovid with #immonoadsorption. The results of this randomized controlled trial will help to answer many questions of this complex disease.

From the ice bear Knut to the bedside - Harald Prüss from @bihatcharite.bsky.social on antibody mediated encephalitis and its treatment by #apheresis.

Prof. Schmidt-Ott and Prof. Klingel opening the 23rd edition of the #apheresis therapy seminar in #Berlin.

Don’t miss arenesdelaplasma.org

Volker Schettler chairing the #apheresis session at the 17th annual meeting of the @dgfn.bsky.social.

If one is not enough: A protocol for extracorporeal triple whammy of #ECMO #CKRT and #TPE in #pediatrics published at onlinelibrary.wiley.com/doi/10.1002/...

How to treat #CDIP by #apheresis? #TPE or #IA? Find answers in a recent analysis 👍 rdcu.be/eALsf

Check out the latest #TAD paper on how to safe water suring dialysis and still perform #HDF. onlinelibrary.wiley.com/doi/10.1111/...

This is how TPE in the ICU looks like in 🇫🇷 prior to the #EXCHANGE-2 trial: Epidemiology of Patients Treated With Plasma Exchange in a French Intensive Care Unit: An Observational Retrospective Study - Dupuis - Therapeutic Apheresis and Dialysis onlinelibrary.wiley.com/doi/full/10....

#seraph 100 to treat preeclampsia? Encouraging in vitro results by Amelie Gienapp et al. onlinelibrary.wiley.com/doi/10.1111/...

Is there a future of lipoprotein apheresis? Read the latest paper by Prof. Schettler www.sciencedirect.com/science/arti...

New data from the World apheresis registry show an increase in #apheresis procedures for neurological diseases. While the total number of procedures did not increase #myasthenia gravis, #Guillain-Barré Syndrome, #multiple sclerosis, #CIDP and #NMOSD were on the rise. www.trasci.com/article/S147...

How to dose drugs in a patient undergoing the extracorporeal triple whammy of #VA-ECMO #CVVHDF and #TPE? An anecdotal answer given in: link.springer.com/article/10.1...

#Apheresis Classics: 1541 citations so far for the seminal paper by Gail Rock et al. Comparison of Plasma Exchange with Plasma Infusion in the Treatment of Thrombotic Thrombocytopenic Purpura | New England Journal of Medicine www.nejm.org/doi/full/10....

E-ISFA Regional 👍

Ken Yamaji (ISFA outgoing president) and Kriengsak Vareesangthip (congress president) hand over the flag of #ISFA to Rasheed Balogun (ISFA incoming president) and Amber Sanchez #ISFA congress president 2027. See you in San Diego.

Apheresis Equipment Market Projected to Reach USD 5 Billion by 2034, Growing at a CAGR of 7.00% The global apheresis equipment market was valued at USD 2.5 billion in 2024 and is expected to grow at a CAGR of 7.0% from 2025 to 2034. The market is driven by growing applications in therapeutic…

Starting day #3 of #ISFA 2025 with talks on rhabdomyolysis and ascites management.

Turn back the clock by #TPE or just another variation to the theme of midlife crisis? Dobri Kiprov is showing that makers of the epigenetic clock are improved after #TPE. An expensive sip from the fountain of youth.

From bed (or in this case PET) to bench - cutting edge research on the effect of Lipoprotein(a) on cardiovascular pathophysiology by @kroonlab.bsky.social at #ISFA 2025.

#photopheresis nicely explained by Jennifer Schneiderman #ISFA 2025.

@tusharchopra.bsky.social summarizing the current status of #green #apheresis at #ISFA 2025. Everybody can implement small steps today!

Laying the foundation of what could be #TPE-MBD (therapeutic plasma exchange associated bone mineral disease) Amber P. Sanchez from @ucsdmedschool.bsky.social with new data on bone markers in #apheresis patients showing an impressive rise in #PTH.

Kornchanok Vareesangthip setting the stage to discuss findings in a national cohort of #apheresis patients.

One world different regulations - Daisuke Katagiri explaining techniques and reimbursement of apheresis in Japan.

Starting day #2 of #ISFA 2025 with a comparison of mTPE and cTPE by Mickael Beraud.

Comparing #TPE and #IA in the setting steroid refractory #MS - Johannes Drost.

Still unavailable in many industrialized countries - excellent overview of #immunoadsorption by Bernd Hohenstein.

Is there a future for lipid apheresis after the advent of pharmaceutical options to lower LDL-C and Lp(a)? Provocative talk by Wolfgang Ramlow showing a remarkably low target attainment in a real life setting at #ISFA2025.

First #E-ISFA session is on lipids. Alfonso Ramunni “Is lipoprotein apheresis effective for coronary microvascular dysfunction in CHD patients?” at #ISFA 2025.

Chairing the two #E-ISFA sessions at #ISFA 2025 : Bernd Hohenstein & Wolfgang Ramlow.

#apheresis is team work and an art - not always as impressive as the opening ceremony of #ISFA 2025.

Ranistha Ratanarat giving a comprehensive overview of adsorptive technologies in #sepsis at #ISFA2025.

#sepsis remains one of the areas with the highest research activity on extracorporeal techniques but with the lowest number of positive RCTs. Excellent overview by Rasheed A. Balogun at #ISFA 2025.

#E-ISFA at #ISFA2025. An interesting program from #apheresis around the world is waiting.